. 1997 Apr;60(4):948–956.
Abstract
The oldest old are the fastest-growing segment of our population and have the highest prevalence of dementia. Little is known about the genetics of cognitive health in the very old. The aim of this study was to determine whether the genetic risk factors for Alzheimer disease (AD)--namely, apolipoprotein E (APOE) epsilon4 allele and a family history of dementia-continue to be important factors in the cognitive health of the very old. Case-control studies suggest that the effect of genetic factors diminishes at age >75 years. The present prospective study provided evidence to the contrary. We studied 114 Caucasian subjects who were physically healthy and cognitively intact at age 75 years and who were followed, for an average of 4 years, with neurological, psychometric, and neuroimaging examinations. Excellent health at entry did not protect against cognitive decline. Incidence of cognitive decline rose sharply with age. epsilon4 and a family history of dementia (independent of epsilon4) were associated with an earlier age at onset of dementia. Subjects who had epsilon4 or a family history of dementia had a ninefold-higher age-specific risk for dementia than did those who had neither epsilon4 nor a family history of dementia. These observations suggest that the rate of cognitive decline increases with age and that APOE and other familial/genetic factors influence the onset age throughout life.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
Bennett C., Crawford F., Osborne A., Diaz P., Hoyne J., Lopez R., Roques P., Duara R., Rossor M., Mullan M. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative. Am J Med Genet. 1995 Feb 27;60(1):1–6. doi: 10.1002/ajmg.1320600102. [DOI] [PubMed] [Google Scholar] Corder E. H., Lannfelt L., Viitanen M., Corder L. S., Manton K. G., Winblad B., Basun H. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol. 1996 May;53(5):418–422. doi: 10.1001/archneur.1996.00550050048022. [DOI] [PubMed] [Google Scholar] Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet. 1994 Jun;7(2):180–184. doi: 10.1038/ng0694-180. [DOI] [PubMed] [Google Scholar] Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Jr, Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E., Tanzi R. E. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology. 1995 Jul;45(7):1323–1328. doi: 10.1212/wnl.45.7.1323. [DOI] [PubMed] [Google Scholar] Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar] Couderc R., Mahieux F., Bailleul S., Fenelon G., Mary R., Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke. 1993 May;24(5):661–664. doi: 10.1161/01.str.24.5.661. [DOI] [PubMed] [Google Scholar] Davignon J., Bouthillier D., Nestruck A. C., Sing C. F. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Trans Am Clin Climatol Assoc. 1988;99:100–110. [PMC free article] [PubMed] [Google Scholar] Davignon J., Gregg R. E., Sing C. F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988 Jan-Feb;8(1):1–21. doi: 10.1161/01.atv.8.1.1. [DOI] [PubMed] [Google Scholar] Duara R., Barker W. W., Lopez-Alberola R., Loewenstein D. A., Grau L. B., Gilchrist D., Sevush S., St George-Hyslop S. Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset. Neurology. 1996 Jun;46(6):1575–1579. doi: 10.1212/wnl.46.6.1575. [DOI] [PubMed] [Google Scholar] Farrer L. A., Cupples L. A., van Duijn C. M., Kurz A., Zimmer R., Müller U., Green R. C., Clarke V., Shoffner J., Wallace D. C. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol. 1995 Nov;38(5):797–808. doi: 10.1002/ana.410380515. [DOI] [PubMed] [Google Scholar] Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990 Mar;31(3):545–548. [PubMed] [Google Scholar] Houlden H., Crook R., Hardy J., Roques P., Collinge J., Rossor M. Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus. Neurosci Lett. 1994 Jun 20;174(2):222–224. doi: 10.1016/0304-3940(94)90026-4. [DOI] [PubMed] [Google Scholar] Howieson D. B., Holm L. A., Kaye J. A., Oken B. S., Howieson J. Neurologic function in the optimally healthy oldest old. Neuropsychological evaluation. Neurology. 1993 Oct;43(10):1882–1886. doi: 10.1212/wnl.43.10.1882. [DOI] [PubMed] [Google Scholar] Jarvik G., Larson E. B., Goddard K., Schellenberg G. D., Wijsman E. M. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet. 1996 Jan;58(1):191–200. [PMC free article] [PubMed] [Google Scholar] Kamino K., Orr H. T., Payami H., Wijsman E. M., Alonso M. E., Pulst S. M., Anderson L., O'dahl S., Nemens E., White J. A. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet. 1992 Nov;51(5):998–1014. [PMC free article] [PubMed] [Google Scholar] Kaye J. A., Oken B. S., Howieson D. B., Howieson J., Holm L. A., Dennison K. Neurologic evaluation of the optimally healthy oldest old. Arch Neurol. 1994 Dec;51(12):1205–1211. doi: 10.1001/archneur.1994.00540240049015. [DOI] [PubMed] [Google Scholar] Kervinen K., Savolainen M. J., Salokannel J., Hynninen A., Heikkinen J., Ehnholm C., Koistinen M. J., Kesäniemi Y. A. Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians. Atherosclerosis. 1994 Jan;105(1):89–95. doi: 10.1016/0021-9150(94)90011-6. [DOI] [PubMed] [Google Scholar] Kuusisto J., Koivisto K., Kervinen K., Mykkänen L., Helkala E. L., Vanhanen M., Hänninen T., Pyörälä K., Kesäniemi Y. A., Riekkinen P. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ. 1994 Sep 10;309(6955):636–638. doi: 10.1136/bmj.309.6955.636. [DOI] [PMC free article] [PubMed] [Google Scholar] Levy-Lahad E., Wasco W., Poorkaj P., Romano D. M., Oshima J., Pettingell W. H., Yu C. E., Jondro P. D., Schmidt S. D., Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995 Aug 18;269(5226):973–977. doi: 10.1126/science.7638622. [DOI] [PubMed] [Google Scholar] Li G., Silverman J. M., Altstiel L. D., Haroutunian V., Perl D. P., Purohit D., Birstein S., Lantz M., Mohs R. C., Davis K. L. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease. Genet Epidemiol. 1996;13(3):285–298. doi: 10.1002/(SICI)1098-2272(1996)13:3<285::AID-GEPI5>3.0.CO;2-5. [DOI] [PubMed] [Google Scholar] Locke P. A., Conneally P. M., Tanzi R. E., Gusella J. F., Haines J. L. Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases. Genet Epidemiol. 1995;12(1):83–92. doi: 10.1002/gepi.1370120108. [DOI] [PubMed] [Google Scholar] McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar] Myers R. H., Schaefer E. J., Wilson P. W., D'Agostino R., Ordovas J. M., Espino A., Au R., White R. F., Knoefel J. E., Cobb J. L. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology. 1996 Mar;46(3):673–677. doi: 10.1212/wnl.46.3.673. [DOI] [PubMed] [Google Scholar] Payami H., Montee K. R., Kaye J. A., Bird T. D., Yu C. E., Wijsman E. M., Schellenberg G. D. Alzheimer's disease, apolipoprotein E4, and gender. JAMA. 1994 May 4;271(17):1316–1317. [PubMed] [Google Scholar] Payami H., Montee K., Kaye J. Evidence for familial factors that protect against dementia and outweigh the effect of increasing age. Am J Hum Genet. 1994 Apr;54(4):650–657. [PMC free article] [PubMed] [Google Scholar] Payami H., Zareparsi S., Montee K. R., Sexton G. J., Kaye J. A., Bird T. D., Yu C. E., Wijsman E. M., Heston L. L., Litt M. Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women. Am J Hum Genet. 1996 Apr;58(4):803–811. [PMC free article] [PubMed] [Google Scholar] Payne M. N., Green E., Walker M. R., Beattie J. M., Murray R. G., Jones A. F. Apolipoprotein epsilon 4 and coronary artery disease. Lancet. 1992 Nov 28;340(8831):1350–1350. [PubMed] [Google Scholar] Pedro-Botet J., Sentí M., Nogués X., Rubiés-Prat J., Roquer J., D'Olhaberriague L., Olivé J. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke. 1992 Nov;23(11):1556–1562. doi: 10.1161/01.str.23.11.1556. [DOI] [PubMed] [Google Scholar] Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993 Sep 18;342(8873):697–699. doi: 10.1016/0140-6736(93)91705-q. [DOI] [PubMed] [Google Scholar] Rao V. S., Cupples A., van Duijn C. M., Kurz A., Green R. C., Chui H., Duara R., Auerbach S. A., Volicer L., Wells J. Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. Am J Hum Genet. 1996 Sep;59(3):664–675. [PMC free article] [PubMed] [Google Scholar] Rebeck G. W., Perls T. T., West H. L., Sodhi P., Lipsitz L. A., Hyman B. T. Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology. 1994 Aug;44(8):1513–1516. doi: 10.1212/wnl.44.8.1513. [DOI] [PubMed] [Google Scholar] Ritchie K., Kildea D. Is senile dementia "age-related" or "ageing-related"?--evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995 Oct 7;346(8980):931–934. doi: 10.1016/s0140-6736(95)91556-7. [DOI] [PubMed] [Google Scholar] Rosenwaike I. A demographic portrait of the oldest old. Milbank Mem Fund Q Health Soc. 1985 Spring;63(2):187–205. [PubMed] [Google Scholar] Saunders A. M., Strittmatter W. J., Schmechel D., George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993 Aug;43(8):1467–1472. doi: 10.1212/wnl.43.8.1467. [DOI] [PubMed] [Google Scholar] Schellenberg G. D., Payami H., Wijsman E. M., Orr H. T., Goddard K. A., Anderson L., Nemens E., White J. A., Alonso M. E., Ball M. J. Chromosome 14 and late-onset familial Alzheimer disease (FAD). Am J Hum Genet. 1993 Sep;53(3):619–628. [PMC free article] [PubMed] [Google Scholar] Schächter F., Faure-Delanef L., Guénot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994 Jan;6(1):29–32. doi: 10.1038/ng0194-29. [DOI] [PubMed] [Google Scholar] Silverman J. M., Li G., Zaccario M. L., Smith C. J., Schmeidler J., Mohs R. C., Davis K. L. Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry. 1994 Jul;51(7):577–586. doi: 10.1001/archpsyc.1994.03950070069012. [DOI] [PubMed] [Google Scholar] Sobel E., Louhija J., Sulkava R., Davanipour Z., Kontula K., Miettinen H., Tikkanen M., Kainulainen K., Tilvis R. Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology. 1995 May;45(5):903–907. doi: 10.1212/wnl.45.5.903. [DOI] [PubMed] [Google Scholar] Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977–1981. doi: 10.1073/pnas.90.5.1977. [DOI] [PMC free article] [PubMed] [Google Scholar] Talbot C., Lendon C., Craddock N., Shears S., Morris J. C., Goate A. Protection against Alzheimer's disease with apoE epsilon 2. Lancet. 1994 Jun 4;343(8910):1432–1433. doi: 10.1016/s0140-6736(94)92557-7. [DOI] [PubMed] [Google Scholar] Tang M. X., Maestre G., Tsai W. Y., Liu X. H., Feng L., Chung W. Y., Chun M., Schofield P., Stern Y., Tycko B. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet. 1996 Mar;58(3):574–584. [PMC free article] [PubMed] [Google Scholar] Tsai M. S., Tangalos E. G., Petersen R. C., Smith G. E., Schaid D. J., Kokmen E., Ivnik R. J., Thibodeau S. N. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet. 1994 Apr;54(4):643–649. [PMC free article] [PubMed] [Google Scholar] West H. L., Rebeck G. W., Hyman B. T. Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease. Neurosci Lett. 1994 Jul 4;175(1-2):46–48. doi: 10.1016/0304-3940(94)91074-x. [DOI] [PubMed] [Google Scholar] Wilson P. W., Myers R. H., Larson M. G., Ordovas J. M., Wolf P. A., Schaefer E. J. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA. 1994 Dec 7;272(21):1666–1671. [PubMed] [Google Scholar] Yu C. E., Payami H., Olson J. M., Boehnke M., Wijsman E. M., Orr H. T., Kukull W. A., Goddard K. A., Nemens E., White J. A. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet. 1994 Apr;54(4):631–642. [PMC free article] [PubMed] [Google Scholar] Zubenko G. S., Stiffler S., Stabler S., Kopp U., Hughes H. B., Cohen B. M., Moossy J. Association of the apolipoprotein E epsilon 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet. 1994 Sep 15;54(3):199–205. doi: 10.1002/ajmg.1320540306. [DOI] [PubMed] [Google Scholar] van Bockxmeer F. M., Mamotte C. D. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet. 1992 Oct 10;340(8824):879–880. doi: 10.1016/0140-6736(92)93288-x. [DOI] [PubMed] [Google Scholar] van Duijn C. M., de Knijff P., Wehnert A., De Voecht J., Bronzova J. B., Havekes L. M., Hofman A., Van Broeckhoven C. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol. 1995 May;37(5):605–610. doi: 10.1002/ana.410370510. [DOI] [PubMed] [Google Scholar]
